BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 8104880)

  • 1. Anti-CD26 monoclonal antibodies can reversibly arrest human T lymphocytes in the late G1 phase of the cell cycle.
    Mattern T; Ansorge S; Flad HD; Ulmer AJ
    Immunobiology; 1993 Jun; 188(1-2):36-50. PubMed ID: 8104880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triggering of the proteinase dipeptidyl peptidase IV (CD26) amplifies human T lymphocyte proliferation.
    Bednarczyk JL; Carroll SM; Marin C; McIntyre BW
    J Cell Biochem; 1991 Jul; 46(3):206-18. PubMed ID: 1723066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of interleukin 2 (IL 2) and interferon-gamma and enhancement of IL 2 receptor expression by a CD26 monoclonal antibody.
    Plana M; Viñas O; De la Calle-Martin O; Lozano F; Inglés-Esteve J; Romero M; Alberola-Ila J; Yagüe J; Vilella R; Vives J
    Eur J Immunol; 1991 Apr; 21(4):1085-8. PubMed ID: 1673434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody binding profile of purified and cell-bound CD26. Designation of BT5/9 and TA5.9 to the CD26 cluster.
    de Meester I; Scharpé S; Vanham G; Bosmans E; Heyligen H; Vanhoof G; Corte G
    Immunobiology; 1993 Jun; 188(1-2):145-58. PubMed ID: 8104877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of murine T cell subsets with anti-CD3 antibody. Age-related defects in the expression of early activation molecules.
    Ernst DN; Weigle WO; McQuitty DN; Rothermel AL; Hobbs MV
    J Immunol; 1989 Mar; 142(5):1413-21. PubMed ID: 2521878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of CD26 (dipeptidyl peptidase IV) on resting and activated human T-lymphocytes.
    Mattern T; Scholz W; Feller AC; Flad HD; Ulmer AJ
    Scand J Immunol; 1991 Jun; 33(6):737-48. PubMed ID: 1675482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzymatic activity of CD26 (dipeptidylpeptidase IV) is not required for its signalling function in T cells.
    Hegen M; Mittrücker HW; Hug R; Demuth HU; Neubert K; Barth A; Fleischer B
    Immunobiology; 1993 Dec; 189(5):483-93. PubMed ID: 7907318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell surface modulation of CD26 by anti-1F7 monoclonal antibody. Analysis of surface expression and human T cell activation.
    Dang NH; Torimoto Y; Sugita K; Daley JF; Schow P; Prado C; Schlossman SF; Morimoto C
    J Immunol; 1990 Dec; 145(12):3963-71. PubMed ID: 1979581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies to TR2 (herpesvirus entry mediator), a new member of the TNF receptor superfamily, block T cell proliferation, expression of activation markers, and production of cytokines.
    Harrop JA; Reddy M; Dede K; Brigham-Burke M; Lyn S; Tan KB; Silverman C; Eichman C; DiPrinzio R; Spampanato J; Porter T; Holmes S; Young PR; Truneh A
    J Immunol; 1998 Aug; 161(4):1786-94. PubMed ID: 9712045
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dipeptidyl peptidase IV (CD26) on human lymphocytes. Synthetic inhibitors of and antibodies against dipeptidyl peptidase IV suppress the proliferation of pokeweed mitogen-stimulated peripheral blood mononuclear cells, and IL-2 and IL-6 production.
    Reinhold D; Bank U; Bühling F; Neubert K; Mattern T; Ulmer AJ; Flad HD; Ansorge S
    Immunobiology; 1993 Aug; 188(4-5):403-14. PubMed ID: 7902330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A cytokine, lymphocyte blastogenesis inhibitory factor (LBIF), arrests mitogen-stimulated T lymphocytes at early G1 phase with no influence on interleukin 2 production and interleukin 2 receptor light chain expression.
    Sugimura K; Ueda Y; Takeda K; Fukuda S; Tsukahara K; Habu Y; Fujiwara H; Azuma I
    Eur J Immunol; 1989 Aug; 19(8):1357-64. PubMed ID: 2673797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Switching on of the proliferation or apoptosis of activated human T lymphocytes by IFN-gamma is correlated with the differential expression of the alpha- and beta-chains of its receptor.
    Novelli F; Bernabei P; Ozmen L; Rigamonti L; Allione A; Pestka S; Garotta G; Forni G
    J Immunol; 1996 Sep; 157(5):1935-43. PubMed ID: 8757312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of CD11a/CD18-CD54 interactions in human T cell-dependent B cell activation.
    Tohma S; Hirohata S; Lipsky PE
    J Immunol; 1991 Jan; 146(2):492-9. PubMed ID: 1670945
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of human T lymphocyte mitogenesis by antibodies to CD3.
    Davis L; Vida R; Lipsky PE
    J Immunol; 1986 Dec; 137(12):3758-67. PubMed ID: 3097131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-T12, an anti-CD6 monoclonal antibody, can activate human T lymphocytes.
    Gangemi RM; Swack JA; Gaviria DM; Romain PL
    J Immunol; 1989 Oct; 143(8):2439-47. PubMed ID: 2794503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous ligation of CD5 and CD28 on resting T lymphocytes induces T cell activation in the absence of T cell receptor/CD3 occupancy.
    Verwilghen J; Vandenberghe P; Wallays G; de Boer M; Anthony N; Panayi GS; Ceuppens JL
    J Immunol; 1993 Feb; 150(3):835-46. PubMed ID: 7678624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-CD26 monoclonal antibody-mediated G1-S arrest of human renal clear cell carcinoma Caki-2 is associated with retinoblastoma substrate dephosphorylation, cyclin-dependent kinase 2 reduction, p27(kip1) enhancement, and disruption of binding to the extracellular matrix.
    Inamoto T; Yamochi T; Ohnuma K; Iwata S; Kina S; Inamoto S; Tachibana M; Katsuoka Y; Dang NH; Morimoto C
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3470-7. PubMed ID: 16740772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis of activated CD8+/CD57+ T cells is induced by some combinations of anti-CD2 mAb.
    Rouleau M; Bernard A; Lantz O; Vernant JP; Charpentier B; Senik A
    J Immunol; 1993 Oct; 151(7):3547-56. PubMed ID: 7690806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comitogenic effect of solid-phase immobilized anti-1F7 on human CD4 T cell activation via CD3 and CD2 pathways.
    Dang NH; Torimoto Y; Deusch K; Schlossman SF; Morimoto C
    J Immunol; 1990 Jun; 144(11):4092-100. PubMed ID: 1971293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional properties of the 50 kd protein associated with the E-receptor on human T lymphocytes: suppression of IL 2 production by anti-p50 monoclonal antibodies.
    Tadmori W; Reed JC; Nowell PC; Kamoun M
    J Immunol; 1985 Mar; 134(3):1709-16. PubMed ID: 2981919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.